Projects per year
- 350 - 400 out of 502 results
Search results
-
Federal Funding Agencies
Exploring functional complexes and disease networks within human RNAbinding protein interactomes
7/1/22 → 6/30/25
Project: Federal Funding Agencies
-
PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PARALLEL-GROUP, STUDY OF AB103 AS COMPARED TO PLACEBO IN PATIENTS WITH NECROTIZING SOFT TISSUE INFECTIONS (NSTI)
Dhala, A., Martinez, S., Mobley, C. M. & Ochoa, R. A.
6/20/17 → 6/19/42
Project: Federal Funding Agencies
-
Carotid Revascularization and Medical Management for Asymptomatic Carotid stenosis - Hemodynamics (CREST-H)
Chiu, D., Gadhia, R. R., Misra, V. & Volpi, J. J.
5/15/17 → 7/31/27
Project: Federal Funding Agencies
-
Targeting the HIV-1 Reservoir in Myeloid Cells
Wang, J. & Li, M.
7/6/21 → 5/31/26
Project: Federal Funding Agencies
-
CAPTIVA- Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis
9/1/21 → 8/31/26
Project: Federal Funding Agencies
-
Molecular Mechanism of Virulence Regulation in Streptococcus Pyogenes
Kumaraswami, M. & Olsen, R. J.
6/7/21 → 5/31/26
Project: Federal Funding Agencies
-
NR4A1 Antagonists Inhibit Colorectal Cancer Growth and Enhance Immune Surveillance
1/1/23 → 12/31/26
Project: Federal Funding Agencies
-
A GMP/GLP investigation of degradable polymeric shells for traumatic osteoregeneration
Taraballi, F., Ihrig, M. & Weiner, B. K.
9/30/15 → 9/29/24
Project: Federal Funding Agencies
-
A novel tool in high- dimensional single-cell space to predict neurotoxicity of CAR T cell therapies
8/1/21 → 7/31/26
Project: Federal Funding Agencies
-
Intranasal Delivery of Telomerase Reverse Transcriptase mRNA for Therapy of Traumatic Brain Injury
9/26/22 → 8/31/24
Project: Federal Funding Agencies
-
XBP1 Inhibition and STING activation for the treatment of cancer
4/8/22 → 3/31/27
Project: Federal Funding Agencies
-
Microbiota-targeted approaches to resolve dysbiosis-induced AD neuropathology following brain injury.
9/15/23 → 8/31/25
Project: Federal Funding Agencies
-
Role of lipid metabolism in CD8+ T cell ferroptosis
9/19/23 → 8/31/28
Project: Federal Funding Agencies
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/24
Project: Federal Funding Agencies
-
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis
Wong, S. T., Chang, J. C. & Sheng, J.
9/15/20 → 8/31/25
Project: Federal Funding Agencies
-
P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy
2/1/22 → 5/31/25
Project: Federal Funding Agencies
-
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer
9/8/23 → 1/31/27
Project: Federal Funding Agencies
-
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
8/1/19 → 7/31/24
Project: Federal Funding Agencies
-
Extended Longevity of 3D Tissues and Microphysiological Systems for Modeling of Acute and Chronic Exposures to Stressors (3DTANDMPS)
3/20/23 → 2/20/27
Project: Federal Funding Agencies
-
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
9/15/22 → 8/31/26
Project: Federal Funding Agencies
-
Targeting DKK1 with a DNA vaccine to prevent development of multiple myeloma
6/26/23 → 12/25/25
Project: Federal Funding Agencies
-
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
8/1/23 → 7/31/28
Project: Federal Funding Agencies
-
POR and Training Program on Multidrug-Resistant Organisms
7/1/22 → 6/30/26
Project: Federal Funding Agencies
-
A Novel Rapidly Deployable mRNA Vaccine Production Platform.
8/21/23 → 8/20/24
Project: Federal Funding Agencies
-
Novel Therapeutic Strategies to Co-Target AR+ and AR-/lo Prostate Cancer Cells
6/1/19 → 5/31/24
Project: Federal Funding Agencies
-
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
6/10/22 → 5/31/27
Project: Federal Funding Agencies
-
Specialty societies advancing adult immunizations in patients with diabetes
10/1/23 → 9/30/25
Project: Federal Funding Agencies
-
Elucidate the effect of biophysical properties evolution in sentinel lymph node of breast cancer on initiating lung metastasis using novel ultrasound poroelastography
2/1/21 → 1/31/25
Project: Federal Funding Agencies
-
SARS-CoV-2 and Precursors of Alzheimer Disease and Related Dementias: An Ultrahigh Field (7T) MRI Study in a Diverse Multinational Cohort
Roman, G. C., Vahidy, F. S. & Masdeu, J. C.
9/1/21 → 8/31/24
Project: Federal Funding Agencies
-
Dual targeting of PI3K and NOS pathways in Metaplastic Breast Cancer (MBC)
7/8/23 → 6/30/28
Project: Federal Funding Agencies
-
MRI Based Calf Muscle Perfusion To Assess Patients with Symptomatic PAD
Bismuth, J. & Shah, D. J.
8/19/19 → 7/31/24
Project: Federal Funding Agencies
-
Non Profit
-
Virtual Reality-Based Cognitive Intervention For The Prevention of Delirium & Cognitive Impairment In Geriatric Surgical Patients
11/15/22 → 11/15/24
Project: Non Profit
-
EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non¿Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature
Bernicker, E. H., Darcourt, J. & Zhang, J.
2/28/19 → 2/27/44
Project: Non Profit
-
AI-Based Characterization of Coronary Artery Disease with Coronary CT Angiogram C00242029
9/1/22 → 8/31/24
Project: Non Profit
-
Lipid Metabolism, Epigenetics, and Intergenerational Control of Lymphatics
7/1/23 → 6/30/25
Project: Non Profit
-
-
Non-invasive spinal neuromodulation and robotic exoskeleton to recover upper limb function after SCI
Sayenko, D., Horner, P. J. & Kaldis, T.
7/31/21 → 7/30/24
Project: Non Profit
-
Role of CstF64 mediated alternative polyadenylation in heart failure
Amirthalingam Thandavarayan, R.
7/1/22 → 6/30/25
Project: Non Profit
-
-
PHASE III RANDOMIZED STUDY OF SORAFENIB PLUS DOXORUBICIN VERSUS SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Bernicker, E. H., Darcourt, J. & Singh, M.
8/13/13 → 8/12/38
Project: Non Profit
-
LONGITUDINAL EARLY ONSET ALZHEIMERâ??S DISEASE (LEADS)
Masdeu, J. C., Faridar, A., Nakawah, M. O. & Pascual, B.
9/15/17 → 5/31/24
Project: Non Profit
-
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study:A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with orwithout Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients withDefici
Abdelrahim, M., Bernicker, E. H., Darcourt, J., Heyne, K. & Singh, M.
3/1/14 → 2/28/39
Project: Non Profit